πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 5 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11944617

Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxe

Corcept Therapeutics Incorporated Β· Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11285145

Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxe

Corcept Therapeutics Incorporated Β· Granted Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8426385

Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation me

Hainan Hdeton Science and Technology Co., Ltd. Β· Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7179588

Assay for the detection of paclitaxel resistant cells in human tumors

The Board of Regents of the University of Texas System Β· Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 6569459

Method of administration of paclitaxel-plasma protein formulation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue May 27 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired